Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nima Etemadi

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
The Biochemical Journal|April 28, 2023
The VEGFR/PDGFR tyrosine kinase inhibitor, ABT-869, blocks necroptosis by targeting RIPK1 kinaseCatia L Pierotti, Annette V Jacobsen, Christoph Grohmann, et al.
Elife|June 28, 2017
Correction: TRAF2 regulates TNF and NF-κB signalling to suppress apoptosis and skin inflammation independently of Sphingosine kinase 1Nima Etemadi, Michael Chopin, Holly Anderton, et al.
Elife|December 25, 2015
TRAF2 regulates TNF and NF-κB signalling to suppress apoptosis and skin inflammation independently of Sphingosine kinase 1Nima Etemadi, Michael Chopin, Holly Anderton, et al.
Science Advances|June 22, 2022
Therapeutic inhibition of the SRC-kinase HCK facilitates T cell tumor infiltration and improves response to immunotherapyAshleigh R Poh, Christopher G Love, David Chisanga, et al.
Elife|December 3, 2014
TNFR1-dependent cell death drives inflammation in Sharpin-deficient miceJames A Rickard, Holly Anderton, Nima Etemadi, et al.
Nature|December 13, 2019
Mutations that prevent caspase cleavage of RIPK1 cause autoinflammatory diseaseNajoua Lalaoui, Steven E Boyden, Hirotsugu Oda, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
The Biochemical Journal|April 28, 2023
The VEGFR/PDGFR tyrosine kinase inhibitor, ABT-869, blocks necroptosis by targeting RIPK1 kinaseCatia L Pierotti, Annette V Jacobsen, Christoph Grohmann, et al.
Elife|June 28, 2017
Correction: TRAF2 regulates TNF and NF-κB signalling to suppress apoptosis and skin inflammation independently of Sphingosine kinase 1Nima Etemadi, Michael Chopin, Holly Anderton, et al.
Elife|December 25, 2015
TRAF2 regulates TNF and NF-κB signalling to suppress apoptosis and skin inflammation independently of Sphingosine kinase 1Nima Etemadi, Michael Chopin, Holly Anderton, et al.
Science Advances|June 22, 2022
Therapeutic inhibition of the SRC-kinase HCK facilitates T cell tumor infiltration and improves response to immunotherapyAshleigh R Poh, Christopher G Love, David Chisanga, et al.
Elife|December 3, 2014
TNFR1-dependent cell death drives inflammation in Sharpin-deficient miceJames A Rickard, Holly Anderton, Nima Etemadi, et al.
Nature|December 13, 2019
Mutations that prevent caspase cleavage of RIPK1 cause autoinflammatory diseaseNajoua Lalaoui, Steven E Boyden, Hirotsugu Oda, et al.
Pageof 2